Radiation therapy (RT) continues to play an important role in the treatment of cancer.
Adaptive RT (ART) is a novel method through which RT treatments are evolving. With the …

Introduction Radiofrequency ablation (RFA) is a standard ablative modality for small liver
malignancies. Stereotactic body radiotherapy (SBRT) has emerged although yet suffers a …

Metastasis is the primary cause of cancer mortality, and cancer frequently metastasizes to
the liver. It is not clear whether liver immune tolerance mechanisms contribute to cancer …

The impact of liver metastases on immune checkpoint-inhibitor effectiveness in patients with
solid-tumor malignancies has been the focus of several recent clinical and translational …

Background & Aims Radiofrequency ablation (RFA) and ablative external beam
radiotherapy (ablative RT) are commonly used to treat small intrahepatic malignancies. We …

Current follow-up policies for early breast cancer aim to detect loco-regional recurrences
and manage treatment-related adverse effects. Their “one size fits all” approach does not …

Abstract Purpose of Review Based on good local control rates and an excellent safety
profile, guidelines consider thermal ablation the gold standard to eliminate small …

MR guided radiotherapy represents one of the most promising recent technological
innovations in the field. The possibility to better visualize therapy volumes, coupled with the …

Nearly one-fifth of patients with non-small cell Lung Cancer (NSCLC) will develop liver
metastases (LMs), and the overall treatment strategy of LMs will directly affect the survival of …

Introduction Stereotactic body radiotherapy (SBRT) is an established ablative treatment for
liver tumors with excellent local control rates. Magnetic resonance imaging guided …